Congress Proposes Medicare and Medicaid Coverage for Prescription Medical Apps and Software
Access to Prescription Digital Therapeutics Act of 2025
Legislative Progress
Key Points
Impact Analysis
Milestones
What Happens Next
Projected impacts based on AI analysis
Related News
5 articlesAccess to Prescription Digital Therapeutics Act reintroduced in Congress
Senators Shelley Moore Capito and Jeanne Shaheen reintroduced the Access to Prescription Digital Therapeutics (PDT) Act to expand Medicare and Medicaid access to software-based treatments. The bill aims to create a new benefit category for FDA-cleared apps treating conditions like autism and PTSD.
Senators Reintroduce Access to Prescription Digital Therapeutics Act
Bipartisan legislation has been reintroduced to increase access to prescription digital therapeutics (PDTs) by creating a Medicare reimbursement pathway. Advocates are using new economic data from Germany to address previous concerns regarding the potential multi-billion dollar cost to Medicare.
Digital Health Startups Seek Path to Medicare Coverage
Startups developing software-based disease treatments are pushing for federal legislation to overcome reimbursement hurdles. The Access to Prescription Digital Therapeutics Act would require CMS to establish payment methodologies for apps prescribed to treat chronic and behavioral conditions.